Elmahboub, Y.; Albash, R.; Agiba, A.M.; Hassan, M.; Mohamed, H.W.; Hassan, M.S.; Ali, R.M.; Shalabi, Y.E.; Omran, H.M.A.; Alaa-Eldin, A.A.;
et al. Overcoming MRSA Antibiotic Resistance Through Losartan Repurposing with Carbon Dot–Conjugated Cerosomal Nanocarriers. Pharmaceutics 2025, 17, 1483.
https://doi.org/10.3390/pharmaceutics17111483
AMA Style
Elmahboub Y, Albash R, Agiba AM, Hassan M, Mohamed HW, Hassan MS, Ali RM, Shalabi YE, Omran HMA, Alaa-Eldin AA,
et al. Overcoming MRSA Antibiotic Resistance Through Losartan Repurposing with Carbon Dot–Conjugated Cerosomal Nanocarriers. Pharmaceutics. 2025; 17(11):1483.
https://doi.org/10.3390/pharmaceutics17111483
Chicago/Turabian Style
Elmahboub, Yasmina, Rofida Albash, Ahmed M. Agiba, Mariam Hassan, Haneen Waleed Mohamed, Mohamed Safwat Hassan, Roaa Mohamed Ali, Yara E. Shalabi, Hend Mahmoud Abdelaziz Omran, Ahmed Adel Alaa-Eldin,
and et al. 2025. "Overcoming MRSA Antibiotic Resistance Through Losartan Repurposing with Carbon Dot–Conjugated Cerosomal Nanocarriers" Pharmaceutics 17, no. 11: 1483.
https://doi.org/10.3390/pharmaceutics17111483
APA Style
Elmahboub, Y., Albash, R., Agiba, A. M., Hassan, M., Mohamed, H. W., Hassan, M. S., Ali, R. M., Shalabi, Y. E., Omran, H. M. A., Alaa-Eldin, A. A., Alamoudi, J. A., Saleh, A., Kassem, A. B., & Eltabeeb, M. A.
(2025). Overcoming MRSA Antibiotic Resistance Through Losartan Repurposing with Carbon Dot–Conjugated Cerosomal Nanocarriers. Pharmaceutics, 17(11), 1483.
https://doi.org/10.3390/pharmaceutics17111483
